Although 4-methylesculetin was not reported as an inhibitor of the NF-κB signaling pathway, a reduction of pro-inflammatory cytokines production, such as IL-1β, IL-6, IL-17, and TNF-α was described in experimental models of intestinal inflammation at same doses [79,84]. This evidence concerns the gene IL1B and gastroenteritis.